Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial.
Medicine (Baltimore). 2023 Nov 3;102(44):e35643. doi: 10.1097/MD.0000000000035643.
Medicine (Baltimore). 2023.
PMID: 37933062
Free PMC article.
Clinical Trial.
Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial.
Dravid A, Pilawan AS, S A, Morkar DN, Ramapuram JT, Madhukarrao KM, Naik KS, Bhrusundi M, K R R, Nageswaramma S, Kulkarni V.
Dravid A, et al. Among authors: bhrusundi m.
Medicine (Baltimore). 2022 Dec 2;101(48):e31982. doi: 10.1097/MD.0000000000031982.
Medicine (Baltimore). 2022.
PMID: 36482530
Free PMC article.
Clinical Trial.
Item in Clipboard
A Phase IV Study on Safety, Tolerability and Efficacy of Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate in Treatment Naïve Adult Indian Patients Living with HIV-1.
Dravid A, Morkar D, Prasad D, Ramapuram JT, Patel KV, Naik KS, Bhrusundi M, Kulkarni M, Hegde S, Anuradha S, Nageswaramma S, Madan S, Jayaprakash T, Kulkarni V.
Dravid A, et al. Among authors: bhrusundi m.
Pragmat Obs Res. 2022 Aug 10;13:75-84. doi: 10.2147/POR.S361907. eCollection 2022.
Pragmat Obs Res. 2022.
PMID: 35975180
Free PMC article.
Item in Clipboard
Cite
Cite